Skip Navigation


Carcinogenesis Advance Access originally published online on July 24, 2009
Carcinogenesis 2009 30(10):1754-1762; doi:10.1093/carcin/bgp182
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/10/1754    most recent
bgp182v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kelleher, M. O.
Right arrow Articles by Hayes, J. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelleher, M. O.
Right arrow Articles by Hayes, J. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

1-Cyano-2,3-epithiopropane is a novel plant-derived chemopreventive agent which induces cytoprotective genes that afford resistance against the genotoxic {alpha},β-unsaturated aldehyde acrolein

Michael O. Kelleher, Michael McMahon, Ian M. Eggleston1, Mark J. Dixon1, Keiko Taguchi2,3,4, Masayuki Yamamoto2,3,4 and John D. Hayes*

Biomedical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK
1 Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK
2 Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai 980-8577, Japan
3 Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba 305-8577, Japan
4 Exploratory Research for Advanced Technology Environmental Response Project, Japan Science and Technology Corporation, Tsukuba 305-8577, Japan

* To whom correspondence should be addressed. Tel: +44 1382 632788; Fax: +44 1382 669993; Email: j.d.hayes{at}dundee.ac.uk

Epithionitriles represent a previously unrecognized class of cancer chemopreventive phytochemical generated from alkenyl glucosinolates in cruciferous vegetables. In rat liver RL-34 epithelial cells, 1-cyano-2,3-epithiopropane (CETP), 1-cyano-3,4-epithiobutane (CETB) and 1-cyano-4,5-epithiopentane (CETPent) were shown to induce cytoprotective enzymes including NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione (GSH) S-transferase A3 and the glutamate–cysteine ligase modifier subunit; CETP was more potent in this regard than were either CETB or CETPent, with 50 µM CETP eliciting a remarkable ~10-fold induction of NQO1. Furthermore, 50 µM CETP stimulated a 2.0-fold overproduction of GSH in RL-34 cells. Transfection experiments demonstrated that epithionitriles induced gene expression through an antioxidant response element (ARE) and that transactivation of an Nqo1-luciferase reporter plasmid was dependent on NF-E2 p45-related factor 2 (Nrf2), a cap'n'collar basic region leucine zipper transcription factor. Evidence is presented that CETP affected Nrf2-mediated induction of ARE-driven transcription by inhibiting Kelch-like ECH-associated protein 1 (Keap1), a ubiquitin ligase substrate adaptor that negatively regulates Nrf2. We found that Nqo1 was expressed constitutively at high levels in Keap1–/– mouse embryonic fibroblasts (MEFs) and it was not further induced by CETP. However, knock-in of mouse Keap1 or zebrafish Keap1a into Keap1–/– MEFs repressed Nqo1-luciferase reporter gene activity, but repression by the murine or zebrafish proteins was antagonized by CETP. Pre-treatment of Nrf2+/+ MEFs, but not Nrf2–/– MEFs, with 15 µM CETP for 24 h conferred 2.4-fold resistance against subsequent exposure to the {alpha},β-unsaturated aldehyde acrolein, indicating that the phytochemical exerts chemopreventive properties against genotoxic xenobiotics.

Abbreviations: AITC, allyl ITC; ARE, antioxidant response element; CETB, 1-cyano-3,4-epithiobutane; CETP, 1-cyano-2,3-epithiopropane; CETPent, 1-cyano-4,5-epithiopentane; CEXB, 1-cyano-3,4-epoxybutane; CEXP, 1-cyano-2,3-epoxypropane; CEXPent, 1-cyano-4,5-epoxypentane; ESP, epithiospecifier protein; GCL, glutamate–cysteine ligase; GCLM, GCL modifier; GSH, glutathione; GST, GSH S-transferase; ITC, isothiocyanate; Keap1, Kelch-like ECH-associated protein 1; LD50, lethal dose 50 (i.e. a dose of xenobiotic that kills 50% of cells); MEF, mouse embryonic fibroblast; mRNA, messenger RNA; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NQO1, NAD(P)H:quinone oxidoreductase 1; Nrf2, NF-E2 p45-related factor 2; PKC, protein kinase C; RT-PCR, real-time polymerase chain reaction; SFN, sulforaphane; Sin, sinigrin

Received May 29, 2009; revised July 1, 2009; accepted July 21, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.